Create SD Holdings Co., Ltd. 3148.T

Healthcare · Pharmaceutical Retailers · valued as of 2026-11-03 · statements 2026-05-31

Average Intrinsic Value
$2.19B
Market Cap
$1.33B
Margin of Safety
39.0%
Intrinsic / Market Ratio
1.64

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

2.25B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.99B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.31B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

2.19B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

2.19B USD

from the sum above

Market Cap

1.33B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.64×

the ratio the screener ranks by; Margin of Safety +39.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 2.25B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)2.02B USD
+②Net Cash Today224.62M USD
+③Growth Value0 USD
=Value2.25B USD

EPV of the Operations (NOPAT over WACC)

2.02B USD

Net cash today

+224.62M USD

Growth Value

0 USD

Value

2.25B USD

①EPV (earnings power value)

2.02B USD

②Net Cash Today

224.62M USD

③Growth Value

0 USD

Market value

Market Cap1.33B USD

Today's price times the shares.

Value vs market

Margin of Safety+40.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.99B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE878.75M USD
+②Equity at Year 15, Today1.12B USD
=Value1.99B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

878.75M USD

②Equity at Year 15, Today

1.12B USD

Market value

Market Cap1.33B USD

Today's price times the shares.

Value vs market

Margin of Safety+33.1%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.31B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.01B USD
+②Invested Capital at Year 15, Today1.08B USD
+③Net Cash Today224.62M USD
=Value2.31B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.01B USD

②Invested Capital at Year 15, Today

1.08B USD

③Net Cash Today

224.62M USD

Market value

Market Cap1.33B USD

Today's price times the shares.

Value vs market

Margin of Safety+42.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.34%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.14×Market Risk Premium 6.00%= 5.37%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 42.07M USDPretax Income 148.85M USD= 28.26%

The tax the interest saves.

Interest Expense =EBIT 148.94M USD−Pretax Income 148.85M USD= 94.27K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 94.27K USDTotal Debt 8.55M USD×(1 − Tax Rate for WACC 28.26%)= 0.79%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 8.55M USDMarket Cap + Total Debt 1.33B USD + 8.55M USD= 0.64%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.36%×Cost of Equity 5.37%+Debt Weight 0.64%×Cost of Debt 0.79%= 5.34%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-05-31.

Total Assets 1.60B USD − Total Liabilities 634.97M USD = Book Value Today 969.89M USD

Total Debt 8.55M USD − Cash and Short-Term Investments 233.16M USD = Net Debt Today -224.62M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.6%at most 5%passes64,602,264 / 64,242,884
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.3%at least -10.0%passes(159.86M USD − 106.78M USD) ÷ 1.60B USD
Price to bookMarket Cap ÷ Book Value Today1.38×at most 3×passes1.33B USD ÷ 969.89M USD
Operating marginOperating Income ÷ Revenue4.8%above 10.0%does not pass150.67M USD ÷ 3.12B USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-1.8%above 10.0%does not pass3.12B USD / 3.18B USD
Net cash(Cash − Total Debt) ÷ Market Cap16.8%above -30%passes(233.16M USD − 8.55M USD) ÷ 1.33B USD
Operating efficiencyOperating Income ÷ Gross Profit18.9%above 25.0%does not pass150.67M USD ÷ 797.89M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

3.24K USD

Enterprise value

173.42B USD

market cap plus net debt

EV / EBITDA

5.67×

Price / book

1.35×

the provider's book

Price / earnings

12.31×

Return on equity

11.4%

the provider's, not the engine's

Profit margin

3.4%

Revenue growth

11.3%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2023202420252026
Income statement

Revenue

2.73B2.69B3.18B3.12B

Gross profit

737.45M702.74M830.02M797.89M

Operating income

135.44M129.03M157.56M150.67M

EBITDA

operating income before depreciation and amortisation

166.59M160.88M192.06M189.43M

Pretax income

133.62M123.42M153.08M148.85M

Net income

92.55M87.32M109.20M106.78M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

96.45M94.21M116.28M113.76M

R&D

————
Balance sheet, year end

Total assets

1.40B1.38B1.65B1.60B

Total liabilities

562.35M550.01M653.32M634.97M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

833.56M830.64M993.63M969.89M

Total debt

——08.55M

Cash and equivalents

268.71M243.70M262.79M233.16M

Net PP&E

fixed assets after depreciation

497.00M536.49M686.79M706.45M

Working capital

current assets less current liabilities

211.09M189.21M190.57M167.51M
Cash flow

Operating cash flow

135.94M134.15M164.48M159.86M

Capital expenditure

paid out, so below zero

-116.75M-100.88M-122.90M-102.74M

Depreciation and amortisation

31.16M31.86M38.97M40.49M

Free cash flow

operating cash flow plus capital expenditure

19.19M33.27M41.58M57.12M